Experimental drug tested for hard-to-treat blood disorder
NCT ID NCT05676697
First seen Feb 13, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This early-phase study tested a drug called Linperlisib in adults with autoimmune hemolytic anemia (AIHA) whose disease did not get better after at least two prior treatments. The goal was to see if the drug could improve red blood cell counts and reduce symptoms. Only 4 people took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE HEMOLYTIC ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Regenerative Medicine Center
Tianjin, Tianjin Municipality, China
-
Zhoukou Central Hospital
Zhoukou, Henan, China
Conditions
Explore the condition pages connected to this study.